{"id":"https://openalex.org/W1545355307","doi":"https://doi.org/10.1017/s1092852900025852","title":"Utilization of Long-Acting Antipsychotic Medication in Patient Care","display_name":"Utilization of Long-Acting Antipsychotic Medication in Patient Care","alternate_titles":[],"publication_year":2006,"publication_date":"2006-12-01","ids":{"openalex":"https://openalex.org/W1545355307","doi":"https://doi.org/10.1017/s1092852900025852","mag":"1545355307","pmid":"https://pubmed.ncbi.nlm.nih.gov/17146411"},"language":"en","primary_location":{"id":"doi:10.1017/s1092852900025852","doi":"https://doi.org/10.1017/s1092852900025852","is_oa":false,"landing_page_url":"https://doi.org/10.1017/s1092852900025852","pdf_url":null,"source":{"id":"https://openalex.org/S4210237982","display_name":"CNS Spectrums","issn_l":"1092-8529","issn":["1092-8529","2165-6509"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Spectrums","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1545355307"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5004031088","display_name":"John Michael Kane","orcid":"https://orcid.org/0000-0002-2628-9442","observed_orcids":["https://orcid.org/0000-0002-2628-9442"]},"institutions":[{"id":"https://openalex.org/I4210166545","display_name":"Zucker Hillside Hospital","ror":"https://ror.org/05vh9vp33","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339","https://openalex.org/I4210166545"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"John M. Kane","raw_affiliation_strings":["Department of Psychiatry, Zucker Hillside Hospital, New York, NY, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Zucker Hillside Hospital, New York, NY, USA","institution_ids":["https://openalex.org/I4210166545"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5004031088"],"corresponding_institution_ids":["https://openalex.org/I4210166545"],"apc_list":{"value":3550,"currency":"USD","value_usd":3550},"apc_paid":null,"fwci":0.9952,"has_fulltext":false,"cited_by_count":39,"citation_normalized_percentile":{"value":0.74037782,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":98},"biblio":{"volume":"11","issue":"S14","first_page":"1","last_page":"8"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13944","display_name":"Psychiatric care and mental health services","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/long-acting-injectable-antipsychotics","display_name":"long-acting injectable antipsychotics","score":0.9440000057220459},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.984000027179718},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.8799999952316284},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.9139999747276306},{"id":"https://openalex.org/keywords/first-episode-psychosis","display_name":"first-episode psychosis","score":0.6819999814033508},{"id":"https://openalex.org/keywords/atypical-antipsychotics","display_name":"atypical antipsychotics","score":0.8999999761581421},{"id":"https://openalex.org/keywords/typical-antipsychotics","display_name":"typical antipsychotics","score":0.8619999885559082},{"id":"https://openalex.org/keywords/tardive-dyskinesia","display_name":"tardive dyskinesia","score":0.9789999723434448},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.6819999814033508},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.6330000162124634}],"concepts":[{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7547804713249207},{"id":"https://openalex.org/C2778715236","wikidata":"https://www.wikidata.org/wiki/Q55622662","display_name":"Discontinuation","level":2,"score":0.696778416633606},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6792408227920532},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.6768712997436523},{"id":"https://openalex.org/C2779158372","wikidata":"https://www.wikidata.org/wiki/Q1546328","display_name":"Tardive dyskinesia","level":3,"score":0.6739498972892761},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.6320947408676147},{"id":"https://openalex.org/C123273963","wikidata":"https://www.wikidata.org/wiki/Q624758","display_name":"Psychopathology","level":2,"score":0.5157644748687744},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.35335367918014526}],"mesh":[{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004333","descriptor_name":"Drug Administration Routes","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004409","descriptor_name":"Dyskinesia, Drug-Induced","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1017/s1092852900025852","doi":"https://doi.org/10.1017/s1092852900025852","is_oa":false,"landing_page_url":"https://doi.org/10.1017/s1092852900025852","pdf_url":null,"source":{"id":"https://openalex.org/S4210237982","display_name":"CNS Spectrums","issn_l":"1092-8529","issn":["1092-8529","2165-6509"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311721","host_organization_name":"Cambridge University Press","host_organization_lineage":["https://openalex.org/P4310311721","https://openalex.org/P4310311702"],"host_organization_lineage_names":["Cambridge University Press","University of Cambridge"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS Spectrums","raw_type":"journal-article"},{"id":"pmid:17146411","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17146411","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"CNS spectrums","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":29,"referenced_works":["https://openalex.org/W95044704","https://openalex.org/W180447486","https://openalex.org/W1816766913","https://openalex.org/W1979191153","https://openalex.org/W1987794435","https://openalex.org/W1988399420","https://openalex.org/W1992857340","https://openalex.org/W2024773049","https://openalex.org/W2031468415","https://openalex.org/W2037633842","https://openalex.org/W2042307019","https://openalex.org/W2054929834","https://openalex.org/W2056330867","https://openalex.org/W2056605307","https://openalex.org/W2107962758","https://openalex.org/W2113319228","https://openalex.org/W2116789320","https://openalex.org/W2127888526","https://openalex.org/W2135689380","https://openalex.org/W2137440611","https://openalex.org/W2154849243","https://openalex.org/W2159155203","https://openalex.org/W2162391751","https://openalex.org/W2166256285","https://openalex.org/W2171958702","https://openalex.org/W2203703767","https://openalex.org/W2409692214","https://openalex.org/W2410785323","https://openalex.org/W3171411502"],"related_works":["https://openalex.org/W1769482660","https://openalex.org/W2003221372","https://openalex.org/W2107352701","https://openalex.org/W1518878597","https://openalex.org/W3038224480","https://openalex.org/W1989794259","https://openalex.org/W1986060217","https://openalex.org/W2971189751","https://openalex.org/W2130874234","https://openalex.org/W2548411673"],"abstract_inverted_index":{"Schizophrenia":[0],"is":[1,52,70,102,107],"a":[2,7,73,96],"complex":[3],"disorder":[4],"characterized":[5],"by":[6],"broad":[8],"spectrum":[9],"of":[10,28,48,60,87,122,142,148,154,161,168],"psychopathology.":[11],"Aggressive":[12],"efforts":[13],"to":[14,54,66,71,105,115],"bring":[15],"the":[16,24,55,85,88,91],"patient":[17],"into":[18],"remission":[19,51],"should":[20],"begin":[21],"immediately":[22],"after":[23],"first":[25],"episode.":[26],"Consequences":[27],"non-remission":[29],"include":[30],"poor":[31],"prognosis,":[32],"psychiatric":[33],"and":[34,40,45,57,90,124,145,152,158],"general":[35],"medical":[36,43],"complications,":[37],"treatment":[38,80,97,100,106,170],"resistance,":[39],"death":[41],"from":[42],"comorbidities":[44],"suicide.":[46],"Prevention":[47],"relapse":[49],"following":[50],"critical":[53],"well-being":[56],"optimal":[58],"functioning":[59],"patients":[61,111],"with":[62,98,112,128],"schizophrenia.":[63],"The":[64],"key":[65],"optimizing":[67],"patients'":[68],"outcomes":[69],"ensure":[72],"patient's":[74,92],"long-term":[75],"continuation":[76],"on":[77],"medication.":[78],"As":[79],"discontinuation":[81],"can":[82],"greatly":[83],"impact":[84],"progression":[86],"illness":[89],"ultimate":[93],"outcome,":[94],"selecting":[95],"maximum":[99],"effectiveness":[101],"optimal.":[103],"Nonadherence":[104],"extremely":[108],"prevalent":[109],"among":[110],"schizophrenia,":[113,149],"due":[114],"such":[116],"factors":[117],"as":[118],"impaired":[119],"cognition,":[120],"lack":[121],"insight,":[123],"side":[125],"effects":[126],"associated":[127],"antipsychotic":[129],"treatment.":[130],"Atypical":[131],"antipsychotics":[132,139,162],"have":[133],"shown":[134],"some":[135],"advantages":[136],"over":[137],"conventional":[138],"in":[140,166],"terms":[141,167],"reducing":[143],"positive":[144],"negative":[146],"symptoms":[147],"preventing":[150],"relapse,":[151],"incidence":[153],"tardive":[155],"dyskinesia.":[156],"Injectables":[157],"long-acting":[159],"formulations":[160],"offer":[163],"additional":[164],"benefits":[165],"ensuring":[169],"adherence.":[171]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1545355307","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
